Implementation of HIV pre-exposure prophylaxis in Colombia
DOI:
https://doi.org/10.18041/2665-427X/ijeph.2.8621Keywords:
prophylaxis , Prevention, Pre-exposition, HIV, Risk groupsAbstract
HIV/AIDS continues to be a global public health problem. Colombia is no exception. New combined prevention approaches can help reduce HIV transmission, such as the use of HIV medications used as pre-exposure prophylaxis (PrEP), combined with the intensification of condom use, which can help end the epidemic by 2030, as proposed by UNAIDS.Downloads
References
1. ONUSIDA. Hoja informativa — Últimas estadísticas sobre el estado de la epidemia de sida. ONUSIDA. ONUSIDA. 2021. Available from: https://www.unaids.org/es/resources/fact-sheet
2. Anderson PL, Glidden D V., Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-Tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012; 4(151): 151ra125-151ra125.
3. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016; 30(12): 1973–83.
4. OPS; OMS. Herramientas de la OMS para la implementación de la profilaxis previa a la infección por el VIH. OPS/CDE/19-004. OMS. 2019. Available from: https://iris.paho.org/handle/10665.2/49782
5. Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, Garnett GP, et al. The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: A mathematical modeling study. PLoS Med. 2012; 9(10): e1001323. doi: 10.1371/journal.pmed.1001323.
6. Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, et al. Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017; 21(5): 1278–87.
7. Silva SC. Explicando la intención de uso de la profilaxis pre-exposición (PrEP) en hombres que tienen sexo con
hombre (HSH) en Chile. Universidad Andrés Bello; 2020 [cited 2021 Jan 14]. Available from: http://repositorio.unab.cl/xmlui/handle/ria/17168.
8. Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: A systematic review of cost-effectiveness modeling studies. PLoS Med. 2013; 10: e1001401.
9. Ravasi G, Grinsztejn B, Baruch R, Guanira JV, Luque R, Cáceres CF, et al. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America. J Internat AIDS Soc. 2016; 19(756): 21113. Doi: 10.7448/IAS.19.7.21113
10. Ministerio de Salud y Protección Social. Prevención combinada, respuesta efectiva en lucha contra VIH/Sida. Ministerio de Salud y Protección Social. 2019. Available from: https://www.minsalud.gov.co/Paginas/Prevencion-combinada-respuesta-efectiva-en-lucha-contra-VIHSida.aspx.
11. Ministerio de Salud y Protección Social. 40 años de avances en la respuesta ante el VIH. Ministerio de Salud y Protección Social; 2019. Available from: https://www.minsalud.gov.co/Paginas/40-anos-de-avances-en-la-respuestaante-el-VIH.aspx
Downloads
Published
Versions
- 2021-07-22 (3)
- 2023-06-14 (2)
- 2021-12-30 (1)
Issue
Section
License
Copyright (c) 2021 Interdisciplinary Journal of Epidemiology and Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
